KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Receivables - Net (2017 - 2025)

Historic Receivables - Net for Amneal Pharmaceuticals (AMRX) over the last 9 years, with Q3 2025 value amounting to $1.4 billion.

  • Amneal Pharmaceuticals' Receivables - Net rose 1905.48% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year increase of 1905.48%. This contributed to the annual value of $1.3 billion for FY2024, which is 865.08% up from last year.
  • Per Amneal Pharmaceuticals' latest filing, its Receivables - Net stood at $1.4 billion for Q3 2025, which was up 1905.48% from $1.3 billion recorded in Q2 2025.
  • Amneal Pharmaceuticals' 5-year Receivables - Net high stood at $1.4 billion for Q3 2025, and its period low was $538.3 million during Q1 2022.
  • Over the past 5 years, Amneal Pharmaceuticals' median Receivables - Net value was $1.2 billion (recorded in 2021), while the average stood at $1.2 billion.
  • As far as peak fluctuations go, Amneal Pharmaceuticals' Receivables - Net soared by 10298.06% in 2021, and later tumbled by 4979.11% in 2022.
  • Amneal Pharmaceuticals' Receivables - Net (Quarter) stood at $1.2 billion in 2021, then rose by 12.85% to $1.3 billion in 2022, then fell by 10.78% to $1.2 billion in 2023, then rose by 8.65% to $1.3 billion in 2024, then rose by 10.8% to $1.4 billion in 2025.
  • Its Receivables - Net was $1.4 billion in Q3 2025, compared to $1.3 billion in Q2 2025 and $1.3 billion in Q1 2025.